Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer

Budzinski et al use bivalent ligands, BRET assays and radioligand competition to demonstrate a specific interaction between two receptors associated with neuropsychiatric diseases and addiction, dopamine D3 (D3R) and neurotensin receptor 1. They show that the bivalent ligands promote endosomal traff...

Full description

Bibliographic Details
Main Authors: Julian Budzinski, Simone Maschauer, Hiroyuki Kobayashi, Pierre Couvineau, Hannah Vogt, Peter Gmeiner, Anna Roggenhofer, Olaf Prante, Michel Bouvier, Dorothee Weikert
Format: Article
Language:English
Published: Nature Publishing Group 2021-09-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-021-02574-4
id doaj-c19eeb6e87c441afa774ebbb7ead711b
record_format Article
spelling doaj-c19eeb6e87c441afa774ebbb7ead711b2021-09-12T11:12:08ZengNature Publishing GroupCommunications Biology2399-36422021-09-014111310.1038/s42003-021-02574-4Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimerJulian Budzinski0Simone Maschauer1Hiroyuki Kobayashi2Pierre Couvineau3Hannah Vogt4Peter Gmeiner5Anna Roggenhofer6Olaf Prante7Michel Bouvier8Dorothee Weikert9Department of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-NürnbergDepartment of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander-Universität Erlangen-NürnbergDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université de MontréalDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université de MontréalDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-NürnbergDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-NürnbergDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-NürnbergDepartment of Nuclear Medicine, Molecular Imaging and Radiochemistry, Friedrich-Alexander-Universität Erlangen-NürnbergDepartment of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université de MontréalDepartment of Chemistry and Pharmacy, Medicinal Chemistry, Friedrich-Alexander-Universität Erlangen-NürnbergBudzinski et al use bivalent ligands, BRET assays and radioligand competition to demonstrate a specific interaction between two receptors associated with neuropsychiatric diseases and addiction, dopamine D3 (D3R) and neurotensin receptor 1. They show that the bivalent ligands promote endosomal trafficking of D3R, suggesting a potential role for dimerization in vivo.https://doi.org/10.1038/s42003-021-02574-4
collection DOAJ
language English
format Article
sources DOAJ
author Julian Budzinski
Simone Maschauer
Hiroyuki Kobayashi
Pierre Couvineau
Hannah Vogt
Peter Gmeiner
Anna Roggenhofer
Olaf Prante
Michel Bouvier
Dorothee Weikert
spellingShingle Julian Budzinski
Simone Maschauer
Hiroyuki Kobayashi
Pierre Couvineau
Hannah Vogt
Peter Gmeiner
Anna Roggenhofer
Olaf Prante
Michel Bouvier
Dorothee Weikert
Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
Communications Biology
author_facet Julian Budzinski
Simone Maschauer
Hiroyuki Kobayashi
Pierre Couvineau
Hannah Vogt
Peter Gmeiner
Anna Roggenhofer
Olaf Prante
Michel Bouvier
Dorothee Weikert
author_sort Julian Budzinski
title Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
title_short Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
title_full Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
title_fullStr Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
title_full_unstemmed Bivalent ligands promote endosomal trafficking of the dopamine D3 receptor-neurotensin receptor 1 heterodimer
title_sort bivalent ligands promote endosomal trafficking of the dopamine d3 receptor-neurotensin receptor 1 heterodimer
publisher Nature Publishing Group
series Communications Biology
issn 2399-3642
publishDate 2021-09-01
description Budzinski et al use bivalent ligands, BRET assays and radioligand competition to demonstrate a specific interaction between two receptors associated with neuropsychiatric diseases and addiction, dopamine D3 (D3R) and neurotensin receptor 1. They show that the bivalent ligands promote endosomal trafficking of D3R, suggesting a potential role for dimerization in vivo.
url https://doi.org/10.1038/s42003-021-02574-4
work_keys_str_mv AT julianbudzinski bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT simonemaschauer bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT hiroyukikobayashi bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT pierrecouvineau bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT hannahvogt bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT petergmeiner bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT annaroggenhofer bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT olafprante bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT michelbouvier bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
AT dorotheeweikert bivalentligandspromoteendosomaltraffickingofthedopamined3receptorneurotensinreceptor1heterodimer
_version_ 1717755930308771840